• Sunho Biologics non-executive director Fan Rongkui will step down on July 22, 2026 as his term ends.
• The board will not renew his service contract; no replacement was announced.
• Fan reported no disagreements with the board; he noted an independent investigation is ongoing with results not yet released.
• Trading in the company’s shares remains suspended since April 1, 2026 pending release of annual results for the year ended Dec. 31, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunho Biologics Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260721-12251718), on July 21, 2026, and is solely responsible for the information contained therein.